Cargando…

Comparative amino acid decomposition analysis of potent type I p38α inhibitors

BACKGROUND AND PURPOSE OF THE STUDY: p38α is a member of mitogen-activated protein kinases (MAPK) considered as a prominent target in development of anti-inflammatory agents. Any abnormality in the phosphorylation process leads to the different human diseases such as cancer, diabetes and inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebadi, Ahmad, Razzaghi-Asl, Nima, Khoshneviszadeh, Mehdi, Miri, Ramin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680208/ https://www.ncbi.nlm.nih.gov/pubmed/23714278 http://dx.doi.org/10.1186/2008-2231-21-41

Ejemplares similares

Ab-initio and Conformational Analysis of a Potent VEGFR-2 Inhibitor: A Case Study on Motesanib
por: Ebadi, Ahmad, et al.
Publicado: (2014)

Effect of Biomolecular Conformation on Docking Simulation: A Case Study on a Potent HIV-1 Protease Inhibitor
por: Razzaghi-Asl, Nima, et al.
Publicado: (2015)

Fragment-based Binding Efficiency Indices in Bioactive Molecular Design: A Computational Approach to BACE-1 Inhibitors
por: Razzaghi-Asl, Nima, et al.
Publicado: (2013)

Novel 9-(alkylthio)-Acenaphtho[1,2-e]-1,2,4-triazine derivatives: synthesis, cytotoxic activity and molecular docking studies on B-cell lymphoma 2 (Bcl-2)
por: Mohammadi, Mohammad K, et al.
Publicado: (2014)

Molecular Modeling of Indeno [1, 2-b] Quinoline-9, 11-Diones as Cytotoxic Agents
por: Miri, Ramin, et al.
Publicado: (2018)

Synthesis, biological evaluation and molecular docking analysis of vaniline–benzylidenehydrazine hybrids as potent tyrosinase inhibitors
por: Iraji, Aida, et al.
Publicado: (2020)

Response Surface Study on Molecular Docking Simulations of Citalopram and Donepezil as Potent CNS Drugs
por: Alikhani, Radin, et al.
Publicado: (2021)

Assessment of the Cytotoxic Effect of a Series of 1,4-Dihydropyridine Derivatives Against Human Cancer Cells
por: Razzaghi-Asl, Nima, et al.
Publicado: (2016)

Design, synthesis, cytotoxicity evaluation and docking studies of 1,2,4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors
por: Ranjbar, Sara, et al.
Publicado: (2018)

Benzylidene-6-hydroxy-3,4-dihydronaphthalenone chalconoids as potent tyrosinase inhibitors
por: Ranjbar, Sara, et al.
Publicado: (2021)

In Silico Screening of IL-1β Production Inhibitors Using Chemometric Tools
por: Sakhteman, Amirhossein, et al.
Publicado: (2017)

Searching for new cytotoxic agents based on chromen-4-one and chromane-2,4-dione scaffolds
por: Gaspar, Alexandra, et al.
Publicado: (2019)

Design and Synthesis of Novel 1-hydroxy-2,4,5-triaryl Imidazole Derivatives as Anti-cytokine Agents
por: Haghighijoo, Zahra, et al.
Publicado: (2020)

Novel Cytotoxic Phenanthro-triazine-3-thiol Derivatives as Potential DNA Intercalators and Bcl-2 Inhibitors
por: Khoshneviszadeh, Mehdi, et al.
Publicado: (2021)

In silico screening and molecular dynamics simulations toward new human papillomavirus 16 type inhibitors
por: Razzaghi-Asl, Nima, et al.
Publicado: (2022)

Phenanthrotriazine Derivatives Containing Arylidine Hydrazone Moieties as Novel Potential c-Met Inhibitors with Anticancer Effect
por: Edraki, Najmeh, et al.
Publicado: (2021)

Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study
por: Shahraki, Omolbanin, et al.
Publicado: (2017)

Synthesis and cytotoxic effect of a few N-heteroaryl enamino amides and dihydropyrimidinethiones on AGS and MCF-7 human cancer cell lines
por: Tavangar, Sajjad, et al.
Publicado: (2020)

Synthesis and antileishmanial effect of a few cyclic and non-cyclic n-aryl enamino amide derivatives
por: Mohammadi-ghalehbin, Behnam, et al.
Publicado: (2020)

Topical Simvastatin Enhances Tissue Regeneration in Full-Thickness Skin Wounds in Rat Models
por: Khoshneviszadeh, Mahsima, et al.
Publicado: (2014)

Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors
por: Khan, Imran Ahmad, et al.
Publicado: (2021)

Bioinformatic analysis of highly consumed phytochemicals as P-gp binders to overcome drug-resistance
por: Rajaei, Narges, et al.
Publicado: (2023)

Synthesis of amantadine clubbed N-aryl amino thiazoles as potent urease, α-amylase & α-glucosidase inhibitors, kinetic and molecular docking studies
por: Zahra, Fatima Tuz, et al.
Publicado: (2023)

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK
por: Halekotte, Jakob, et al.
Publicado: (2017)

Novel amino-β-lactam derivatives as potent cholesterol absorption inhibitors
por: Dražić, Tonko, et al.
Publicado: (2014)

Synthesis, cytotoxic assessment, and molecular docking studies of 2,6-diaryl-substituted pyridine and 3,4- dihydropyrimidine-2(1H)-one scaffolds
por: HOSSEINZADEH, Zahra, et al.
Publicado: (2020)

Synthesis and cytotoxicity evaluation of novel cyclic/non-cyclic N-aryl enamino amides against human cancer cell lines
por: Bohlooli, Shahab, et al.
Publicado: (2020)

Design, Synthesis and SAR Studies of NAD Analogues as Potent Inhibitors towards CD38 NADase
por: Wang, Shengjun, et al.
Publicado: (2014)

Effect of different physical factors on the synthesis of spherical gold nanoparticles towards cost‐effective biomedical applications
por: Bahmanyar, Zahra, et al.
Publicado: (2022)

Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
por: Sahu, Vishal, et al.
Publicado: (2019)

p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening
por: Astolfi, Andrea, et al.
Publicado: (2015)

Comparative chemical array screening for p38γ/δ MAPK inhibitors using a single gatekeeper residue difference between p38α/β and p38γ/δ
por: Kondoh, Yasumitsu, et al.
Publicado: (2016)

OA01.38. Anti-obesity activity of Zizyphyus mauritiana lam: a potent pancreatic lipase inhibitor
por: Deshpande, M. S., et al.
Publicado: (2012)

Design, Synthesis and Biological Evaluation of Novel Substituted N,N′-Diaryl ureas as Potent p38 Inhibitors
por: Zhu, Dianxi, et al.
Publicado: (2015)

Design, synthesis, and evaluation of novel racecadotril-tetrazole-amino acid derivatives as new potent analgesic agents
por: Asadi, Mehdi, et al.
Publicado: (2021)

A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity
por: Lu, Cai, et al.
Publicado: (2021)

Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives
por: Razzaghi-Asl, Nima, et al.
Publicado: (2019)

Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study
por: Abuelizz, Hatem A., et al.
Publicado: (2019)

Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors
por: Pedrood, Keyvan, et al.
Publicado: (2022)

COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2
por: Oubahmane, Mehdi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tgq9t4nme7s6ipcf5k8isdm682